ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction

OBJECTIVES: Anoctamin 1 (ANO1) has been found to be overexpressed in esophageal squamous cell carcinoma (ESCC) in our previous study. Herein we showed the clinical relevance of ANO1 alterations with ESCC and esophageal precancerous lesion progression. RESULTS: ANO1 was detected in 38.1% (109/286) an...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Shang, Li, Hao, Jia-Jie, Zhao, Xue-Ke, He, Jian-Zhong, Shi, Zhi-Zhou, Liu, Hui-Juan, Wu, Li-Fei, Jiang, Yan-Yi, Shi, Feng, Yang, Hai, Zhang, Yu, Liu, Yi-Zhen, Zhang, Tong-Tong, Xu, Xin, Cai, Yan, Jia, Xue-Mei, Li, Min, Zhan, Qi-Min, Li, En-Min, Wang, Li-Dong, Wei, Wen-Qiang, Wang, Ming-Rong
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029708/
https://ncbi.nlm.nih.gov/pubmed/27016410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8223
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller